GGrantIndex
← Search

VALIDATING VIL-6 AS A TARGET FOR KSHV-ASSOCIATED DISEASE

$35,312P51FY2008RRNIH

Oregon Health & Science University, Portland OR

Investigators

Linked publications & trials

View original record on NIH RePORTER →